CCL2 and Alzheimer disease: A variety of biomarkers for microglial activation in AD have been proposed, such as chitotriosidase, CCL18 (pulmonary activation-regulated chemokine; PARC), YKL-40, CCL2 (monocyte chemoattractant protein 1; MCP-1), CD14, and neopterin [140].